Antimicrobial prescription errors in hospitalized children: role of antimicrobial stewardship program in detection

M Cecilia Di Pentima1, Shannon Chan, Stephen C Eppes

  • 1Alfred I. duPont Hospital for Children, Nemours Children's Clinic, Wilmington, Delaware 19803, USA. cdipenti@nemours.org

Clinical Pediatrics
|February 20, 2009
PubMed

Insights

Implementing an antimicrobial stewardship program (ASP) effectively reduced antimicrobial prescription errors in hospitalized children. This strategy ensures appropriate antibiotic use, improving patient outcomes and minimizing resistance.

Area of Science:

  • Pediatric Infectious Diseases
  • Hospital Pharmacy and Therapeutics
  • Antimicrobial Resistance

Background:

  • Antimicrobial stewardship programs (ASP) are crucial for optimizing antibiotic use, improving patient outcomes, and reducing healthcare costs.
  • Effective ASP implementation is vital for combating antimicrobial resistance (AMR).
  • This study evaluates the impact of an ASP on antimicrobial (AM) prescription errors.

Purpose of the Study:

  • To assess the effectiveness of an antimicrobial stewardship program in reducing AM prescription errors.
  • To analyze the impact of active surveillance and system optimization on AM prescribing practices in pediatric patients.

Main Methods:

  • A prospective, single-center study was conducted at a tertiary pediatric teaching hospital.
  • Active monitoring of 13 targeted antimicrobials and microbiology data was performed.
  • The ASP was implemented using CareNet and PharmNet, with interventions guided by an infectious disease physician and pharmacist.

Main Results:

  • A total of 5564 dispensed prescriptions for 13 targeted AMs were screened.
  • The rate of AM errors was found to be 0.09 per 1000 doses administered.
  • An incidence of 5 AM errors per 1000 patient days was recorded.

Conclusions:

  • Active surveillance combined with an optimized computerized physician order entry system facilitates early detection of AM prescription errors.
  • This approach enables timely intervention, significantly reducing AM prescription errors in hospitalized children.
  • The findings underscore the importance of robust ASPs in pediatric settings to ensure safe and effective antimicrobial use.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...